ImmuneSense™ IBD Study

TerminatedOBSERVATIONAL
Enrollment

484

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

August 14, 2023

Study Completion Date

August 14, 2023

Conditions
Inflammatory Bowel Diseases
Trial Locations (6)

15401

Frontier Clinical Research, LLC, Uniontown

33010

Hope Clinic & Research Center LLC, Hialeah

33155

Gold Coast Health Research Center, LLC, Miami

Sanitas Research, Miami

78526

Gastroenterology Consultants of South Texas, PA, Brownsville

02904

University Gastroenterology, Providence

Sponsors
All Listed Sponsors
lead

Adaptive Biotechnologies

INDUSTRY